UK Archives | FinSMEs

Basma.com Raises $3M in Series A Funding

BASMA.com, a London, UK-based digital healthcare platform working for orthodontics focused on MENA, raised $3M in Series A funding.

Beamery Raises US$138M in Series C Funding

Beamery, a London, UK-based operating system for companies to attract, engage and retain top talent, raised US$138m in Series C funding.

Apollo Therapeutics Raises $145M in Funding

Apollo Therapeutics, a Cambridge UK-based biopharmaceutical company focused on advancing treatments based on breakthrough discoveries, raised $145M in funding.

onHand Raises £1M in Funding

onHand, a London, UK-based on-demand volunteering app, raised £1m in funding.

ShareVision Raises $2.1M in Seed Funding

ShareVision, a London, UK-based provider of a financial streaming platform, raised $2.1m in seed funding.

Macrina Kgil, CFO, Positions Blockchain.com for IPO

Blockchain.com’s Chief Financial Officer (CFO), Macrina Kgil, continues to lead the company through a series of financial movements that leave it well-positioned to go public in the future.

Otherworld Raises £2.9M in Funding

Otherworld, a London, UK – based maker and provider of an out-of-home virtual reality experience, raised £2.9M ($4.1M) in funding.

10x Future Technologies Raises $187M in Series C Funding

10x Future Technologies, a London, UK-based fintech company, raised $187m in Series C financing.

Isomer Capital Holds First Close of €100M Opportunities Fund

Isomer Capital, a London, UK-based venture capital firm, held the first close of its new $100m opportunities fund.

Ophelos Raises $2.3M in Funding

Ophelos, a London UK-debt management platform company, raised $2.3M in funding.

XYZ Reality Raises £20M in Series A Funding

XYZ Reality, a London, UK-based engineering-grade augmented reality company, raised £20m in Series A funding.

Immersive Labs Raises $75M in Series C Funding

Immersive Labs, a Bristol, UK- and Boston, MA-based company provider of a platform for organizations to measure and improve cybersecurity skills across technical and non-technical teams, closed $75m Series C funding round.

Actimed Therapeutics Closes £2.5M Extended Seed B Funding Round

Actimed Therapeutics Ltd, a London, UK-based clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, with a focus on cachexia, closed its extended Seed B financing round which has raised in excess of £2.5m.